Navigation Links
Tekni-Plex, Inc. Announces Expiration Of Change Of Control Offer To Purchase Its 9.750% Senior Secured Notes Due 2019
Date:1/13/2014

KING OF PRUSSIA, Pa., Jan. 13, 2014 /PRNewswire/ -- Tekni-Plex, Inc. (the "Company") today announced the expiration of its previously announced offer to purchase (the "Offer") any and all of its outstanding 9.750% senior secured notes due 2019 (the "Notes"). The Offer was made solely to fulfill the Company's obligations under the indenture governing the Notes following the consummation on December 13, 2013 of the previously announced merger (the "Merger") with an affiliate of American Securities LLC, which resulted in a "Change of Control" giving the holders of the Notes the right to require the Company to purchase all or a portion of such holders' Notes at a purchase price of 101% of the principal amount thereof, plus any accrued and unpaid interest up to, but not including, the date of purchase.

The Offer was commenced on December 13, 2013 and expired at 5:00 P.M., New York City Time, on Friday, January 10, 2014 (the "Expiration Date"). As of the Expiration Date, $74,000 in aggregate principal amount of the Notes (representing approximately 0.02% of the outstanding Notes) had been delivered for repurchase pursuant to the Offer.  Payment for the tendered notes will occur on January 15, 2014.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities.

About Tekni-Plex, Inc.

Tekni-Plex, Inc. is a global manufacturer of technically-sophisticated products and components engineered to meet critical customer needs in niche applications. The Company operates in three segments: Healthcare, Specialty Packaging and Food Packaging. Tekni-Plex's primary products include closure liners, medical tubing, high-barrier pharmaceutical films, medical compounds, dispensing components and thermoformed containers.   The Company is headquartered in King of Prussia, PA and operates 25 manufacturing facilities across nine countries worldwide to meet the needs of its global customers. For more information on the capabilities of Tekni-Plex, visit www.tekni-plex.com or call the Company at (484) 690-1520.

Contact:
Graham Sayers
Executive Vice President &
Chief Financial Officer
Graham.Sayers@Tekni-Plex.com


'/>"/>
SOURCE Tekni-Plex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tekni-Plex, Inc. To Hold Teleconference To Discuss Financial Results For Fiscal Year 2013 On September 12, 2013
2. Debiopharm Group Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty
3. Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation
4. Medical Tracking Solutions, Inc. announces new client NovaBone Products, LLC
5. Volcano Corporation Announces Preliminary Fourth Quarter 2013 Revenues; Year-Over-Year Annual Revenues Increase Eight Percent On A Constant Currency Basis
6. Millennium Laboratories Announces Strategic Acquisition of RxAnte
7. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
8. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
9. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
10. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
11. Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
(Date:12/7/2016)... 2016 The global  blood ... of USD 3.9 billion by 2024, based on ... The growth of the market is attributed to ... advancements by the market players. Demand for blood ... donation, rising awareness about transfusion-transmitted diseases, and technological ...
(Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
Breaking Medicine Technology:
(Date:12/7/2016)... New York, NY (PRWEB) , ... December 07, ... ... measurable amounts of the drug in their bodies, a researcher at the Icahn ... the journal Pediatric Research. , The study found that when young children are ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning of ... an emergency medical call when he lost control of his patrol car. The vehicle ... his vehicle, he was transported to Atlanta Medical Center, where he later succumbed to ...
(Date:12/7/2016)... ... December 07, 2016 , ... They are musicians and librarians, ... wives, brothers and fathers, from New England and around the nation. What do they ... are brought together in a beautiful and compelling new photographic exhibit debuting Friday, December ...
(Date:12/7/2016)... ... 07, 2016 , ... Augustine Insurance Agency, a locally owned ... owners in the greater Dallas metropolitan area, is announcing a charity event that ... Established in 2009 by active police professionals in the Dallas region, the Dallas ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Sharon Kleyne, host ... Climate Change and Your Health on Voice of America, declared on her radio program ... attention to the fact that when these bullies attack leaders in corporate America, they ...
Breaking Medicine News(10 mins):